Tiziana Life Sciences (TLSA) to Present BANYAN Phase 2a Poster at ALS Nexus
TLSA Tiziana Life Sciences Ltd
$1.15 +0.88%
View chart & analysis → 
- 1Tiziana Life Sciences (TLSA) will present a poster on the Phase 2a BANYAN trial of intranasal foralumab at ALS Nexus 2026
- 2In an Orlando Monday poster session, Dr. Pinar Uysal will cover preclinical data, trial design, and MyMatch screening
- 3BANYAN is a 3-to-1 randomized, placebo-controlled, multicenter trial now in the initiation phase
This 3-line summary is compiled from the report below.
Proactive +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다